P3NET members have collaborated with the following organizations:

• Basilea Pharmaceutica
• EUMEDICA SA
• Wockhardt Ltd
• BioVersys AG
• Astellas
• Mundipharma
• Shionogi
• Advanz              
• GSK
• Janssen
• Novavax
• Pfizer
• Roche
• Sanofi

European consortia

P3NET members regularly participate in European consortia (i.e., Horizon, MSCA, IMI/IHI):

• 2011-2017 Horizon AIDA
• 2014-2018 IMI New Drugs 4 Bad Bugs” (COMPACTE MAGNET)

• 2019-2024 MSCA DN TIPAT

• 2019-2024 IMI2 JU AMR Accelerator program GNA-NOW
• 2019-2024 IMI2 JU AMR Accelerator program: RespiriTB

• 2019-2024 IMI2 JU AMR Accelerator program RespiriNTM

• 2019-2021 IMI2 JU AMR Accelerator program AB-DiRecT

• 2021-2025, VACCELERATE Grant of HORIZON 2020

• 2026, BE READY NOW – EUROPEAN PARTNERSHIP FOR PANDEMIC PREPAREDNESS

• 2026, FACT – HORIZON-JU-GH-EDCTP3-2025-01-MALARIA-02: Malaria therapeutics